Alignment Healthcare, Inc. (ALHC) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $7.42 (-8.00%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 6, 2026 | Jessica Tassan | Piper Sandler | $30.00 | +304.6% |
| Nov 3, 2025 | Scott Fidel | Goldman Sachs | $22.00 | +196.7% |
| Oct 31, 2025 | Kevin Caliendo | UBS | $18.00 | +142.8% |
| Aug 25, 2025 | Matthew Gillmor | KeyBanc | $21.00 | +183.2% |
| Aug 14, 2024 | Michael Ha | Robert W. Baird | $11.00 | +48.3% |
| Aug 5, 2024 | Andrew Mok | Barclays | $7.00 | -5.6% |
| Jul 26, 2024 | Craig Jones | Stifel Nicolaus | $12.00 | +61.8% |
| May 8, 2024 | Jessica Tassan | Piper Sandler | $8.00 | +7.9% |
| Oct 16, 2023 | John Ransom | Raymond James | $10.00 | +34.9% |
| Oct 12, 2023 | Scott Fidel | Stephens | $9.00 | +21.4% |
Top Analysts Covering ALHC
ALHC vs Sector & Market
| Metric | ALHC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.50 | 2.25 | 2.41 |
| Analyst Count | 10 | 8 | 19 |
| Target Upside | +65.8% | +153002.0% | +21.5% |
| P/E Ratio | 81.13 | 3.39 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.11B | $5.17B | $5.19B | 10 |
| 2027-03-31 | $1.47B | $1.53B | $1.58B | 4 |
| 2027-06-30 | $1.58B | $1.65B | $1.71B | 4 |
| 2027-09-30 | $1.57B | $1.64B | $1.69B | 5 |
| 2027-12-31 | $1.57B | $1.64B | $1.70B | 4 |
| 2028-03-31 | $1.78B | $1.86B | $1.92B | 3 |
| 2028-06-30 | $1.97B | $2.05B | $2.12B | 3 |
| 2028-09-30 | $1.90B | $1.98B | $2.04B | 5 |
| 2028-12-31 | $1.90B | $1.99B | $2.05B | 3 |
| 2029-12-31 | $10.11B | $10.44B | $10.82B | 3 |
| 2030-12-31 | $13.21B | $13.65B | $14.14B | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.04 | $0.13 | $0.35 | 6 |
| 2027-03-31 | $0.06 | $0.06 | $0.06 | 2 |
| 2027-06-30 | $0.19 | $0.20 | $0.21 | 1 |
| 2027-09-30 | $0.12 | $0.13 | $0.13 | 1 |
| 2027-12-31 | $-0.03 | $-0.03 | $-0.03 | 2 |
| 2028-03-31 | $0.12 | $0.13 | $0.14 | 3 |
| 2028-06-30 | $0.29 | $0.31 | $0.32 | 2 |
| 2028-09-30 | $0.25 | $0.26 | $0.27 | 2 |
| 2028-12-31 | $0.04 | $0.04 | $0.04 | 3 |
| 2029-12-31 | $1.18 | $1.23 | $1.29 | 1 |
| 2030-12-31 | $1.60 | $1.67 | $1.75 | 1 |
Frequently Asked Questions
What is the analyst consensus for ALHC?
The consensus among 10 analysts covering Alignment Healthcare, Inc. (ALHC) is Buy with an average price target of $19.00.
What is the highest price target for ALHC?
The highest price target for ALHC is $30.00, set by Jessica Tassan at Piper Sandler on 2026-01-06.
What is the lowest price target for ALHC?
The lowest price target for ALHC is $7.00, set by Andrew Mok at Barclays on 2024-08-05.
How many analysts cover ALHC?
10 analysts have issued ratings for Alignment Healthcare, Inc. in the past 12 months.
Is ALHC a buy or sell right now?
Based on 10 analyst ratings, ALHC has a consensus rating of Buy (2.50/5) with a +65.8% upside to the consensus target of $19.00.
What are the earnings estimates for ALHC?
Analysts estimate ALHC will report EPS of $0.13 for the period ending 2026-12-31, with revenue estimated at $5.17B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.